Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Latent profile analysis for quality of life in older patients.
Băjenaru L, Balog A, Dobre C, Drăghici R, Prada GI. Băjenaru L, et al. Among authors: balog a. BMC Geriatr. 2022 Nov 11;22(1):848. doi: 10.1186/s12877-022-03518-1. BMC Geriatr. 2022. PMID: 36368920 Free PMC article.
Comparative single-cell multiplex immunophenotyping of therapy-naive patients with rheumatoid arthritis, systemic sclerosis, and systemic lupus erythematosus shed light on disease-specific composition of the peripheral immune system.
Balog JÁ, Zvara Á, Bukovinszki V, Puskás LG, Balog A, Szebeni GJ. Balog JÁ, et al. Among authors: balog a. Front Immunol. 2024 Apr 25;15:1376933. doi: 10.3389/fimmu.2024.1376933. eCollection 2024. Front Immunol. 2024. PMID: 38726007 Free PMC article.
Au-decorated Sb2Se3 photocathodes for solar-driven CO2 reduction.
Dela Cruz JMCM, Balog Á, Tóth PS, Bencsik G, Samu GF, Janáky C. Dela Cruz JMCM, et al. Among authors: balog a. EES Catal. 2024 Jan 16;2(2):664-674. doi: 10.1039/d3ey00222e. eCollection 2024 Mar 7. EES Catal. 2024. PMID: 38464594 Free PMC article.
Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohort.
Parodis I, Lindblom J, Barturen G, Ortega-Castro R, Cervera R, Pers JO, Genre F, Hiepe F, Gerosa M, Kovács L, De Langhe E, Piantoni S, Stummvoll G, Vasconcelos C, Vigone B, Witte T; PRECISESADS Clinical Consortium; Alarcón-Riquelme ME, Beretta L. Parodis I, et al. Ann Rheum Dis. 2024 Feb 19:ard-2023-224795. doi: 10.1136/ard-2023-224795. Online ahead of print. Ann Rheum Dis. 2024. PMID: 38373843 Free article.
Association of Combined Anti-Ro52/TRIM21 and Anti-Ro60/SSA Antibodies With Increased Sjögren Disease Severity Through Interferon Pathway Activation.
Bettacchioli E, Saraux A, Tison A, Cornec D, Dueymes M, Foulquier N, Hillion S, Roguedas-Contios AM, Benyoussef AA, Alarcon-Riquelme ME, Pers JO, Devauchelle-Pensec V; PRECISESADS Clinical Consortium, and PRECISESADS Sjögren Consortium. Bettacchioli E, et al. Arthritis Rheumatol. 2024 May;76(5):751-762. doi: 10.1002/art.42789. Epub 2024 Feb 14. Arthritis Rheumatol. 2024. PMID: 38130019
High-content multimodal analysis supports the IL-7/IL-7 receptor axis as a relevant therapeutic target in primary Sjögren's syndrome.
Desvaux E, Hemon P, Soret P, Le Dantec C, Chatzis L, Cornec D, Devauchelle-Pensec V; PRECISESADS clinical consortium; Elouej S, Duguet F, Laigle L, Poirier N, Moingeon P, Bretin S, Pers JO. Desvaux E, et al. J Autoimmun. 2023 Dec 18:103147. doi: 10.1016/j.jaut.2023.103147. Online ahead of print. J Autoimmun. 2023. PMID: 38114349
160 results